PF-03654746 Uses, Dosage, Side Effects and more
PF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome, and Excessive Daytime Sleepiness.
Trade Name | PF-03654746 |
Generic | PF-03654746 |
Type | |
Formula | C18H24F2N2O |
Weight | Average: 322.4 Monoisotopic: 322.185669727 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |